Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
30.76
-0.29 (-0.93%)
Apr 28, 2026, 2:41 PM EDT - Market open
HRMY Market Cap
HRMY has a market cap or net worth of $1.78 billion as of April 28, 2026. Its market cap has increased by 6.99% in one year.
Market Cap
1.78B
Enterprise Value
1.17B
1-Year Change
6.99%
Ranking
Category
Stock Price
$30.76
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $1.78B, an increase of 286.09%. That is a compound annual growth rate of 26.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.80B | -16.63% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 1.87B |
| Recursion Pharmaceuticals | 1.85B |
| Taysha Gene Therapies | 1.84B |
| Vericel | 1.82B |
| Palvella Therapeutics | 1.77B |
| Rapport Therapeutics | 1.75B |
| Innoviva | 1.75B |
| Nurix Therapeutics | 1.72B |